Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. The Atlas System represents a new tier of molecular rapid pathogen testing, offering automation and technology that bring true walk-away convenience and workflow advantages to the laboratory. Its focus on food safety Roka delivers accurate and reliable test results for food pathogens regardless of sample type.


Type
Public
HQ
Warren, US
Founded
2009
Size (employees)
90 (est)
Roka Bioscience was founded in 2009 and is headquartered in Warren, US
Report incorrect company information

Key People/Management at Roka Bioscience

Paul G. Thomas

Paul G. Thomas

Chairman of the Board
David R. Patterson

David R. Patterson

Vice President of Manufacturing Operations
Lars Boesgaard

Lars Boesgaard

Vice President, CFO

Roka Bioscience Office Locations

Roka Bioscience has an office in Warren
Warren, US (HQ)
20 Independence Boulevard
Show all (1)
Report incorrect company information

Roka Bioscience Financials and Metrics

Roka Bioscience Financials

Roka Bioscience's revenue was reported to be $7.24 m in FY, 2016 which is a 21% increase from the previous period.
USD

Revenue (Q2, 2017)

2.1 m

Gross profit (Q2, 2017)

(95 k)

Gross profit margin (Q2, 2017), %

(4.4%)

EBIT (Q2, 2017)

(17.4 m)

Market capitalization (22-Dec-2017)

3.3 m

Cash (30-Jun-2017)

2.4 m
Roka Bioscience's current market capitalization is $3.3 m.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

5.1 m6 m7.2 m

Revenue growth, %

18%21%

Cost of goods sold

8 m

Gross profit

(732 k)
Quarterly
USDQ2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

1.5 m1.5 m1.6 m1.8 m1.9 m2 m2.1 m

Cost of goods sold

1.8 m1.7 m2.1 m2 m2 m2.1 m2.2 m

Gross profit

(289 k)(164 k)(450 k)(224 k)(99 k)(72 k)(95 k)

Gross profit Margin, %

(20%)(11%)(28%)(12%)(5%)(4%)(4%)
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

7.5 m3.4 m8.8 m

Accounts Receivable

375 k

Inventories

4.9 m3.9 m3.7 m

Current Assets

51.4 m42.1 m35.1 m
Quarterly
USDQ1, 2017Q2, 2017

Cash

1.3 m2.4 m

Inventories

4.1 m4.1 m

Current Assets

23.3 m18.3 m

PP&E

7.4 m3.7 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

(32.2 m)(36.6 m)(30.8 m)

Depreciation and Amortization

4.2 m6.2 m5.8 m

Inventories

(2.8 m)690 k(638 k)

Accounts Payable

(465 k)4.1 m(362 k)
Quarterly
USDQ2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Depreciation and Amortization

937 k937 k939 k939 k939 k937 k

Inventories

4.7 m4.9 m4.5 m4.4 m3.9 m3.8 m3.9 m4.1 m

Accounts Payable

882 k868 k495 k413 k610 k582 k1.1 m758 k
USDY, 2017

Financial Leverage

2.5 x
Show all financial metrics
Report incorrect company information